Migraine

Current Location

45 Migraine Trials Near You

Power is an online platform that helps thousands of Migraine patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.

Learn More About Power
No Placebo
Highly Paid
Stay on Current Meds
Pivotal Trials (Near Approval)
Breakthrough Medication
This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized treatment for headache day reduction.
No Placebo Group

Trial Details

Trial Status:Recruiting
Trial Phase:Unphased
Age:10 - 17

260 Participants Needed

The main goal of this trial is to learn whether eptinezumab improves migraine symptoms and quality of life of participants with migraine who did not perceive a sufficient improvement during previous treatment with therapies targeting calcitonin gene-related peptide (CGRP).
No Placebo Group

Trial Details

Trial Status:Recruiting
Trial Phase:Phase 4

150 Participants Needed

Erenumab for Migraine

Cleveland, Ohio
This trial tests if erenumab, an injection given regularly, can reduce migraine days in children and adolescents with chronic migraines by blocking a protein that triggers these headaches. Erenumab has been shown to reduce migraine days and improve quality of life in adults with chronic and episodic migraines.
Pivotal Trial (Near Approval)

Trial Details

Trial Status:Active Not Recruiting
Trial Phase:Phase 3
Age:6 - 17

284 Participants Needed

This trial is testing a type of therapy called Mindfulness-Based Cognitive Therapy, provided over the phone, through video calls, or as part of regular care with added support. It aims to help people with migraines and depressive symptoms by teaching them to focus on the present moment and understand their thought patterns better. Mindfulness-Based Cognitive Therapy (MBCT) was developed to prevent relapse in recurrent depression by combining cognitive behavioral therapy and meditative techniques.
No Placebo Group

Trial Details

Trial Status:Recruiting
Trial Phase:Unphased

144 Participants Needed

Rimegepant for Migraine

Ann Arbor, Michigan
The purpose of this study is to learn about the effect of a study medicine called rimegepant in adolescents who have frequent migraine attacks. Rimegepant is a tablet that dissolves when you put it on or under your tongue. The study will enroll participants who have headache for 15 days (or more) every month, of which 8 days (or more) of migraine every month, and each untreated attack lasts for an average of 4-72 hours In the 1st part of the study approximately half of the participants will receive a rimegepant tablet every other day, and approximately half of the participants will receive an inactive oral tablet (that looks the same as the rimegepant tablet) every other day. Participant experiences when they are taking the study medicine will be compared to when they are taking the inactive tablet. This will help to determine if the study medicine is safe and effective. The 1st phase of the study will last 3 months. In the 2nd part of the study all the participants who stay on study will receive rimegepant tablet every other day. This 2nd phase of the study will last 1 year. This will help determine if the study medicine is safe when taken for a long period. Those who will participate in both phases will have up to 19 visits at the study clinic, about one every 4 weeks (this may vary from 2 to 8 weeks interval during the study). Home health visits may occur as well. A health check and blood sample will be conducted at all visits. Participants will have to complete a daily diary to record the migraine attacks.
Pivotal Trial (Near Approval)

Trial Details

Trial Status:Recruiting
Trial Phase:Phase 3
Age:12 - 17

200 Participants Needed

This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications

Trial Details

Trial Status:Active Not Recruiting
Trial Phase:Phase 4
Age:18 - 65

658 Participants Needed

Rimegepant for Migraine

Ann Arbor, Michigan
This study is being conducted to evaluate the efficacy and tolerability of rimegepant in a population of adults that are unsuitable for triptan medications due to a previous intolerance, lack of efficacy, or contraindication (including a history of clinically-relevant cardiovascular disease).

Trial Details

Trial Status:Active Not Recruiting
Trial Phase:Phase 4
Age:18 - 65

633 Participants Needed

A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head. It is often accompanied by feeling or being sick and a sensitivity to bright lights and sound. Migraines are caused by a series of events when the brain gets stimulated or activated, which causes the release of chemicals that cause pain. IPN10200 is a medication that stops the release of these chemical messengers. Participants with episodic migraine (EM) or chronic migraine (CM) will be included in both Step 1 and Step 2. "Headache days" are when participants experience headaches that meet the criteria for a migraine or a headache without the additional migraine-specific symptoms. "Migraine days" occur when the headache displays clear migraine characteristics. This study aims to determine: * The safety and efficacy of injecting IPN10200 directly into the muscles of the head and neck to prevent EM and CM, * The right amount (dose) of IPN10200 to inject at each point, * The total amount (dose) of IPN10200 that provides the best balance between safety and efficacy preventing migraines. Participants will need to complete a daily electronic migraine Diary (eDiary) and questionnaires throughout the study. The total study duration for a participant will be up to 44 weeks.

Trial Details

Trial Status:Recruiting
Trial Phase:Phase 2

641 Participants Needed

People with chronic migraine headaches face many challenges, including high levels of daily pain, disturbances to everyday activities and sleep, and problems with mood such as depression or anxiety. This trial is being completed to study whether changing an individual's behaviors may have an impact as a treatment for migraine headaches. Eligible participants will be randomized to one of the four arms. This study will be conducted remotely without in-person contact. Study Hypothesis: * There is a main effect of attending either the Empowered Relief and Health Education intervention on reductions in migraine-related disability 1 month after completing either intervention * There is a main effect of Empowered Relief and Health Education interventions on reducing pain-related catastrophizing and migraine symptom severity 1 month after completing either intervention (secondary hypothesis) * The expected reductions in migraine-related disability, pain catastrophizing, and migraine symptom severity will be maintained at secondary time points (2 months, 3 months, and 6 months after completing either intervention) (secondary hypothesis)
No Placebo Group

Trial Details

Trial Status:Recruiting
Trial Phase:Unphased

300 Participants Needed

This study investigates whether unilateral and bilateral non-invasive brain stimulation, given for 20 minutes/once per day for twenty days (M-F) can reduce migraine pain. Fourty patients will receive treatment (20 unilateral treatment, and 20 bilateral treatment), while twenty will receive a "sham" procedure. Another 20 Episodic Migraine patients will be recruited for the observational aim of the study which does not include brain stimulation.

Trial Details

Trial Status:Recruiting
Trial Phase:Unphased
Age:18 - 65

80 Participants Needed

MMA Embolization for Migraine

Morgantown, West Virginia
This is a prospective, multi-center, feasibility study to investigate safety and effectiveness of TRUFILL n-BCA liquid embolic system in bilateral middle meningeal artery (MMA) embolization for the treatment of refractory chronic migraine.
No Placebo Group

Trial Details

Trial Status:Recruiting
Trial Phase:Unphased
Age:18 - 65

50 Participants Needed

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in women who experience menstrual migraine attacks.
Pivotal Trial (Near Approval)

Trial Details

Trial Status:Recruiting
Trial Phase:Phase 3
Age:18 - 45
Sex:Female

723 Participants Needed

Atogepant for Migraine

Smithfield, Pennsylvania
Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. The goals of the study are to evaluate adverse events and how well treatment of atogepant works compared to placebo (looks like the study treatment but contains no medicine) in preventing chronic migraine in participants between 12 and 17 years of age. Atogepant is a medicine currently approved in the United States and Europe for the preventive treatment of migraine in adult patients with migraine and is being studied for the preventative treatment of chronic migraine in participants between the ages of 12 and 17 years. Participants will be randomly assigned to one of the 2 groups to be treated with either atogepant or placebo. This study is double-blinded, which means that neither the patients nor the study doctors know who is given which study treatment. Approximately 420 participants 12 to 17 years of age with chronic migraine will be enrolled at approximately 70 sites across the world. Participants will receive oral tablets of atogepant or placebo once daily for 12 weeks and will be followed for 4 weeks. Participants will attend regular visits during the study at a hospital or clinic and the effects of treatment will be checked by completion of a daily diary, medical assessments, blood tests, checking for side effects, and completing questionnaires.
Pivotal Trial (Near Approval)

Trial Details

Trial Status:Recruiting
Trial Phase:Phase 3
Age:12 - 17

420 Participants Needed

MTX101 for Migraine

Farmington Hills, Michigan
The goal of this clinical trial is to learn if drug MTX101 works to treat acute migraine attacks in adults. It will also learn about the safety of the drug MTX101. The main questions it aims to answer are: Does the drug MTX101 lower headache pain for participants and the need to use a rescue medication? What side effects, if any, do participants have when taking the drug MTX101? Researchers will compare the drug MTX101 to a placebo (a look-alike substance that contains no drug) to see if the drug MTX101 works to treat acute migraine attacks. Participants will: Take the drug MTX101 or a placebo to treat 1 migraine attack with each treatment. Visit the clinic twice and have one phone call over a 4 week period for checkups and tests. Keep a diary of their symptoms and the number of times they use a rescue medication.

Trial Details

Trial Status:Recruiting
Trial Phase:Phase 2
Age:18 - 65

72 Participants Needed

MEDI0618 for Migraine

Crab Orchard, West Virginia
The purpose of this Phase 2 study is to evaluate the safety and efficacy of SC MEDI0618 compared to placebo in participants with episodic migraine.

Trial Details

Trial Status:Active Not Recruiting
Trial Phase:Phase 2

12 Participants Needed

Why Other Patients Applied

"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."

ZS
Depression PatientAge: 51

"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."

HZ
Arthritis PatientAge: 78

"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."

FF
ADHD PatientAge: 31

"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."

IZ
Healthy Volunteer PatientAge: 38

"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."

ID
Pancreatic Cancer PatientAge: 40

Know someone looking for new options? Spread the word

Learn More About Power

Why We Started Power

We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.

Bask
Bask GillCEO at Power
Learn More About Trials

Frequently Asked Questions

How much do Migraine clinical trials pay?

Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.

How do Migraine clinical trials work?

After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Migraine trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Migraine is 12 months.

How do I participate in a study as a "healthy volunteer"?

Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.

What does the "phase" of a clinical trial mean?

The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.

Do I need to be insured to participate in a Migraine medical study?

Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.

What are the newest Migraine clinical trials?

Most recently, we added MMA Embolization for Migraine, Rimegepant for Menstrual Migraine and Elismetrep for Migraine to the Power online platform.

What are the current treatments for migraines?

Migraine care has two parts: 1) fast-acting medicines for an attack, which range from simple pain relievers to triptans, newer CGRP blockers (ubrogepant, rimegepant), the ditan lasmiditan, ergotamine/DHE, and even handheld nerve-stimulation devices; and 2) preventive strategies taken regularly—beta-blockers, anti-seizure or antidepressant drugs, CGRP monoclonal-antibody injections, atogepant tablets, Botox, plus consistent sleep, exercise and trigger management—to cut down how often headaches occur. Doctors match these tools to your migraine frequency, other health conditions and side-effect risks, and will step up to preventive therapy if you still have about four or more disabling headache days per month.

What is the root cause of migraine?

Migraine starts with an inherited “hyper-excitable” brain network—particularly in the brain-stem and trigeminal pain pathways—that can be set off by waves of nerve activity (called cortical spreading depression) and the release of pain chemicals like CGRP. Hormone shifts, lack of sleep, certain foods, or stress don’t create the disease; they simply lower the threshold and provoke attacks in someone who already has this biological vulnerability. Knowing this helps you focus on both preventive medicines that calm those brain pathways and lifestyle steps that avoid personal triggers.

What is a chronic migraine that won't go away?

Chronic migraine means you suffer headaches on 15 or more days each month for at least three months, with at least eight of those days having typical migraine features; it is a long-term pattern, not a single marathon attack (that latter problem is called status migrainosus). The condition is usually tackled by limiting trigger factors and medication-overuse while starting a preventive treatment—such as daily oral drugs, periodic Botox injections, or the newer once-monthly CGRP antibody shots—under the guidance of a neurologist or headache specialist. Seek urgent care if any single attack lasts beyond 72 hours or suddenly feels different, as that could signal status migrainosus or another emergency.

Does drinking electrolytes help with migraines?

Electrolyte drinks are useful mainly when a migraine is brought on by dehydration—replacing both water and minerals can shorten or stop those attacks. Research shows only magnesium (about 400–600 mg a day) has real preventive benefit; extra sodium or potassium hasn’t been proven helpful and can be risky if you have heart, kidney or blood-pressure issues. Aim for steady daily hydration, use an electrolyte solution after heavy sweating or illness, and check with your doctor before taking regular magnesium or high-salt products.

What are the 5 C's of migraines?

The “5 C’s” are five foods and drinks that some people notice can spark a migraine: cheese, chocolate, coffee, cola (or other caffeinated soft drinks), and citrus fruits. They are only possible triggers—each one bothers certain individuals because of ingredients like tyramine or caffeine—so the practical way to find out if they affect you is to log what you eat and when headaches start, then review that pattern with your healthcare provider before cutting anything out.

Do migraines get worse with age?

For most people migraines are worst in their 20s-40s and slowly ease after about age 50, particularly once the hormonal ups-and-downs of perimenopause settle. That said, attacks can flare at any age if triggers pile up—hormone shifts, stress, poor sleep, or frequent use of pain relievers—so a new or noticeably different headache pattern after 50 deserves a medical check-up to rule out other causes. Keeping a trigger diary, limiting acute medicines, and asking your clinician about modern preventives (from CGRP blockers to lifestyle coaching) can stop migraines from feeling “worse with age.”

Why can't we cure migraines?

Migraine isn’t one simple defect but a tangle of many factors—dozens of genes, changing hormones, brain-wave events like “cortical spreading depression,” and pain chemicals such as CGRP—so blocking a single switch can’t cure every patient without also risking side-effects. Instead, doctors manage it by combining quick-relief drugs (triptans, newer CGRP blockers) with preventives (CGRP antibodies, beta-blockers, Botox, nerve-stimulation devices) while researchers keep mapping the circuitry to design even more targeted fixes. In short: we can’t yet erase migraine for everyone, but understanding is growing fast and today’s tailored treatments already let many people live nearly attack-free.

What are G pants for migraines?

“G-pants” is a nickname for “gepants,” a new group of oral (and one nasal-spray) migraine drugs—ubrogepant, rimegepant, atogepant and zavegepant—that block the CGRP receptor, a chemical switch that helps trigger migraine pain. Taken either at the start of an attack (ubrogepant, rimegepant, zavegepant) or once daily/every other day to cut the number of attacks (atogepant, rimegepant), they offer relief without the blood-vessel-tightening risk of older triptans; the most typical side-effects are mild nausea, fatigue or taste changes. Ask your doctor whether gepants fit your situation, especially if you have heart-disease risks or haven’t done well on triptans.

How do you break a chronic migraine?

Think of it in two steps. 1) If a migraine has dragged on for 3-plus days, a headache specialist can “break” it with short-term measures such as a triptan or NSAID taken early, a brief oral steroid taper, or in clinic/ER infusions like dihydroergotamine, IV metoclopramide, or a newer “gepant” pill; these reset the attack without causing medication-overuse headache. 2) To keep it from becoming chronic again, you need daily prevention tailored to you—common options are onabotulinumtoxinA shots or once-monthly CGRP-antibody injections, strict trigger and sleep hygiene, and limiting pain pills to <10 days a month—reviewed every few months with a headache specialist.

What toxin is used for migraines?

Doctors use onabotulinumtoxinA, best known by the brand name Botox, to prevent chronic migraine—defined as at least 15 headache days a month—when standard preventive medicines haven’t helped. Every 12 weeks a neurologist injects tiny amounts into about 31 spots across the scalp, forehead, and neck; this can cut monthly headache days by roughly 7-9 days, with the most common side-effects being temporary neck pain or mild eyelid droop. Ask your headache specialist whether you meet the criteria and whether any other medical conditions or medications would make this treatment unsuitable for you.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security